Recruiting CEBPA to the promoter of PLK2 negatively regulates its expression.40 Therefore, like its role in acute myeloid leukemia, CEBPA is recognized as an antitumor TF in osteosarcoma. Here, CEBPA is linked to osteosarcoma.